Login / Signup
Han Li
ORCID
Publication Activity (10 Years)
Years Active: 2024-2024
Publications (10 Years): 1
Top Topics
Inflammatory Response
Free Survival
Metastatic Breast Cancer
Diffusion Weighted
Top Venues
Molecular cancer therapeutics
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Hangtian Yue
,
Hui Xu
,
Lanping Ma
,
Xiyuan Li
,
Biyu Yang
,
Xiyuan Wang
,
Qingzhong Zeng
,
Han Li
,
Deqiang Zhang
,
Meiyu Geng
,
Tao Meng
,
Zuoquan Xie
A DXd/TLR7-agonist dual-conjugate anti-HER2 ADC exerts robust anti-tumor activity through tumor cell killing and immune activation.
Molecular cancer therapeutics
(2024)